Urinary Tract Infection Bacterial Clinical Trials
2 recruiting trials for Urinary Tract Infection Bacterial. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Urinary Tract Infection Bacterial clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 4 (2 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by University of Louisville (1), Thomas Benfield (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Povidone-Iodine (drug, 1 trial), followed by Sterile water, Shortened antibiotic treatment.
Track Urinary Tract Infection Bacterial trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Betadine vs Sterile Water for Periurethral Preparation
The purpose of this study is to determine whether cleaning of the urethra, or external opening to the bladder, with sterile water (water that has been treated to remove bacteria...
Shortened Antibiotic Treatment of 5 Days in Gram-negative Bacteremia
GNB5 is an investigator-initiated multicentre non-inferiority randomized controlled trial which aims to assess the efficacy and safety of shortened antibiotic for patients...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Urinary Tract Infection Bacterial, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Urinary Tract Infection Bacterial, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Urinary Tract Infection Bacterial, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.